Patient Data Security Basics

Patient data security starts with the workflow, not a software label. Before approving a tool, identify what patient information it handles, where that information goes, who can access it, what monitoring reveals, and which services any applicable business associate agreement (BAA) covers.

What patient data security means in everyday clinic work

Patient data security means protecting patient information while supporting appropriate access for clinic work. Privacy concerns include whether someone should access or use that information; security controls help protect it against unauthorized access, disclosure, alteration, or loss.

Protected health information, or PHI, broadly refers to individually identifiable health information within HIPAA’s scope. Its precise definition and boundaries matter when deciding what a workflow contains. Under 45 CFR §160.103, PHI includes individually identifiable health information transmitted or maintained in any medium, subject to exclusions for specified education records, employer-held employment records, and information about people deceased for more than 50 years. Properly de-identified information is not PHI. The Privacy Rule governs PHI in electronic, paper, and oral forms, including permitted uses and disclosures and individual rights; the Security Rule protects the confidentiality, integrity, and availability of electronic PHI.

Consider these hypothetical situations:

• A referral attachment arrives in an email inbox.
• Staff share a patient document through a file-sharing service.
• A scheduling application sends an appointment reminder.
• A staff member opens a medication record.

Each raises different questions about recipients, permissions, storage, and visibility. None is approved for PHI simply because the tool is commonly used in healthcare.

Access controls and privacy monitoring serve different purposes. Permissions help determine who can open a record. Monitoring supports review of access activity and its context. Neither establishes, by itself, that every access is appropriate.

Start with a practical checklist:

• Map where the information moves.
• Check who can access it.
• Examine what activity can be reviewed.
• Confirm applicable BAA coverage before approval.

For the broader distinction between a product claim and organizational responsibilities, see what HIPAA compliant means.

Which kinds of patient data security software should you evaluate?

“Patient privacy software,” “patient data privacy software,” and “PHI data security software” are broad search terms, not precise product categories. Ask vendors which workflow and risk their product addresses.

Function	Purpose to evaluate	Questions to ask
Everyday clinic applications	Handle information during email, scheduling, file sharing, or other work	What data enters the service, and where can it go?
Access-management controls	Manage identities, permissions, and account access	Who grants access, changes permissions, and removes departing staff?
Activity logging	Record defined actions within a system	Which events are recorded, with what detail, and for how long?
Dedicated patient privacy monitoring	Support review of access activity for potential privacy concerns	Which systems and events can it examine, and how are concerns investigated?

An activity log is not equivalent to dedicated privacy monitoring. A log might record that a user opened a record without explaining whether that access matched the user’s responsibilities. Do not assume a monitoring product supplies that missing context: request evidence.

Use the same comparison fields for every candidate:

• Purpose: Which specific problem would it address?
• Data accessed: Patient records, access logs, attachments, or other information?
• BAA scope: Which plan, services, and uses are covered?
• Access controls: Who can administer the system or view its contents?
• Monitoring evidence: What can a reviewer actually inspect?
• Operational owner: Who maintains the configuration and follows up?

You can compare software by category, then evaluate individual candidates against the same workflow.

Map where patient information moves

The following referral workflow is illustrative, not compliant by design.

Receipt: A referring office sends a patient document to a clinic inbox. Identify the receiving service, the intended recipients, and whether forwarding sends copies elsewhere.

Storage: A coordinator saves the attachment in a shared folder. Check the folder’s membership, sharing settings, and whether staff download local copies.

Staff access: A clinician opens the document. Determine how access is granted and what evidence records the action.

Onward sharing: Staff send part of the referral to another organization or enter information into another application. Identify the recipient, destination service, and applicable agreement and configuration.

Include easily overlooked destinations in the inventory:

• Reminder services and message-delivery providers.
• Spreadsheet exports and downloaded reports.
• Files synchronized to staff devices.
• Connected applications and automation services.
• AI features that receive text, attachments, or conversation context.

At each handoff, ask: Which organization receives the information? Which service processes or stores it? What agreement and configuration apply?

Do not assume the original application’s BAA extends to every connected destination. Treat connected services as separate review items, and evaluate AI tools before sharing PHI.

Check BAA coverage before approving a tool

A statement that a vendor offers a BAA is the beginning of a scope review, not its conclusion.

Check:

• Whether a BAA is available on the clinic’s intended plan.
• Which named services and data types it covers.
• Which features, uses, or destinations it excludes.
• Whether add-ons and connected services have separate terms.
• Whether the agreement has been signed and applies to the intended use.

For example, imagine a scheduling service whose trust page says a BAA is available. That statement alone does not establish whether the clinic’s subscription, reminder add-on, exported reports, or AI assistant falls within the agreement. The actual terms must resolve those questions.

Ask about feature changes as well as contract changes. Enabling an integration may create a new destination for patient information even when the main application stays the same.

Use the guide to read a vendor BAA for plans, covered services, and exclusions.

Directory verdicts are yes, conditional, no, or unknown, supported by vendor-owned BAA or trust sources. Without a source, the verdict is unknown. A verdict should be read alongside its plan restrictions, scope, exclusions, and dedicated source and review record—not as an unconditional approval of the product.

Evaluate privacy monitoring for medication records and clinician access

If your clinic is handling more medication records or clinician access activity, evaluate monitoring against that actual workload. A “best-in-class” label is not a substitute for evidence that a product fits your systems and review process.

Ask vendors to demonstrate the following using representative, non-patient test data.

Area	Demonstration questions
Source coverage	Which of our systems and access events can you ingest? What is not captured?
User and patient context	What information helps reviewers understand who accessed which record and why?
Investigation evidence	Can a reviewer reconstruct an event and inspect the underlying evidence?
Alert configuration	What triggers an alert, and which settings can we change?
Review workflow	How are concerns assigned, escalated, documented, and closed?
Workload	How are false positives handled, and what ongoing review effort is expected?

These are evaluation questions, not capabilities every product provides.

Consider a hypothetical alert about a staff member opening a medication record outside their usual work area. An investigator would need to ask:

• Was the person covering another team or responding to a legitimate request?
• Is the user identity reliable?
• What action occurred: opening, editing, exporting, or something else?
• What context is missing from the available evidence?
• What additional review is needed?

An unusual event does not prove misconduct. Conversely, a system’s failure to generate an alert does not establish that every access was appropriate.

Assess fit against your source systems, event volume, deployment needs, contractual scope, reviewer capacity, and total costs—including implementation and ongoing review. More alerts are not automatically better protection.

Assess open-source and self-hosted options separately

Open-source licensing describes how software is made available; it is not evidence that a particular deployment is suitable for PHI. Self-hosting also does not answer who can access the information or who maintains the system.

For an open-source protected health information software project—or any self-hosted application—ask:

• Operations: Who runs it and responds when it fails?
• Location: Where do application data, logs, exports, and backups reside?
• Access: Can hosting providers, contractors, or support staff view patient information?
• Updates: Who evaluates and applies security fixes?
• Logs: What activity is recorded, and who reviews it?
• Recovery: How are backups protected and restoration procedures tested?
• Agreements: Which parties handle patient information, and what agreements apply?

Do not assume open-source software always requires a BAA, never requires one, or is inherently safer than commercial software. The deployment and service relationships need their own assessment.

These are due-diligence prompts, not a complete legal checklist. Use them alongside the guide to evaluate an application's HIPAA requirements.

Use a repeatable approval checklist

Keep an approval record that answers:

• Intended workflow: What will staff actually do?
• Data involved: What patient information enters, leaves, or remains in the system?
• Accountable owner: Who maintains the approval and configuration?
• Access model: Who can view, change, share, or export information?
• Monitoring evidence: What can reviewers inspect, and who investigates concerns?
• BAA scope: Where applicable, which plan, services, and exclusions govern the use?
• Connected services: Which integrations, AI features, and downstream providers need review?
• Unresolved questions: What must be answered before approval?

Document the decision, supporting evidence, and restrictions. Reassess when the plan, enabled features, connected services, or vendor terms change.

Use the directory to check a vendor's BAA availability and scope and the guide to respond when a vendor changes its BAA terms.

Published by Chanty, Inc. The directory reports published vendor information; it does not audit vendors, and payment does not determine category placement. This guide is not legal advice, certification, or a complete compliance program.

Sources and review notes

Frequently asked questions

What is patient data security software?

It is a broad term for software used to protect patient information or support its appropriate use. It may refer to everyday applications with access controls, identity tools, logging systems, or dedicated privacy monitoring. Evaluate the specific function rather than the label.

How does patient privacy monitoring differ from an activity log?

An activity log records defined events. Dedicated monitoring may help identify and investigate potential privacy concerns across those events. Ask what context and review capabilities the product actually provides; a log alone does not establish whether access was appropriate.

What should we ask monitoring vendors about medication records and clinician access?

Ask which source systems and events they support, what patient and user context is available, and whether reviewers can reconstruct an event. Also examine alert handling, false positives, escalation, documentation, and the staff time needed for review.

Does a signed BAA cover every feature and integration?

Do not assume so. Check the agreement’s named services, plan requirements, exclusions, and treatment of add-ons, integrations, AI features, and downstream providers. The clinic’s exact workflow must be evaluated against that scope.

Can open-source software be used with protected health information?

Open-source status alone neither approves nor rules out a deployment. Review its operation, hosting, access, updates, logs, backups, support arrangements, and applicable agreements before approving PHI use.

Does buying security software make a practice HIPAA compliant?

No. A software purchase, monitoring deployment, or signed BAA does not make a practice HIPAA compliant by itself. Configuration, access management, staff practices, contractual scope, and ongoing responsibilities still need attention.